Headquartered in Carlsbad, CA Fiscal year ends December NASDAQ: ATEC atecspine.com
Alphatec Holdings, Inc. (ATEC) is a medical device company focused exclusively on spine surgery, operating through its wholly owned subsidiaries Alphatec Spine, Inc., EOS imaging S.A.S., and SafeOp Surgical, Inc. The company develops and commercializes innovative surgical approaches, instruments, implants, and informatics platforms designed to improve the safety, reproducibility, and outcomes of spine surgery. ATEC's product portfolio spans its proprietary InformatiX platform, which integrates surgical planning, intraoperative monitoring (via SafeOp), and imaging (via EOS) to provide a data-driven procedural approach. The company generates revenue through two primary streams: surgical revenue from spine surgery products and procedures, and EOS revenue from its advanced imaging systems. ATEC targets surgeon adoption through clinical innovation and differentiated workflows, serving the broader spine surgery market. Updated
Pre-Market Stock Futures: Futures are trading lower after a big rate-cut rally on Wednesday was sideswiped by Oracle’s disappointing earnings after the bell yesterday. The Federal Reserve’s 25-basis-point rate cut, as expected,…
With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for Alphatec.
Alphatec Holdings, Inc. (ATEC) is a medical device company focused exclusively on spine surgery, operating through its wholly owned subsidiaries Alphatec Spine, Inc., EOS imaging S.A.S., and SafeOp Surgical, Inc.
The Wall Street consensus 12-month price target for ATEC is $15.79.
